LPCAT1
Basic information
Region (hg38): 5:1456480-1524282
Previous symbols: [ "AYTL2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LPCAT1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 28 | 29 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 28 | 1 | 1 |
Variants in LPCAT1
This is a list of pathogenic ClinVar variants found in the LPCAT1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-1463683-C-T | not specified | Uncertain significance (Dec 04, 2023) | ||
5-1463733-G-A | not specified | Likely benign (Aug 26, 2024) | ||
5-1463742-G-A | not specified | Uncertain significance (Apr 24, 2024) | ||
5-1463773-G-T | not specified | Uncertain significance (Jan 10, 2023) | ||
5-1463797-C-T | not specified | Uncertain significance (Nov 09, 2024) | ||
5-1463812-T-C | not specified | Uncertain significance (May 14, 2024) | ||
5-1463817-G-C | Likely benign (Apr 01, 2022) | |||
5-1466761-T-G | not specified | Uncertain significance (Aug 19, 2024) | ||
5-1466868-C-T | not specified | Uncertain significance (Oct 05, 2021) | ||
5-1470826-C-T | Benign (May 18, 2018) | |||
5-1470827-T-C | not specified | Uncertain significance (Dec 20, 2021) | ||
5-1470865-C-T | Benign (May 18, 2018) | |||
5-1470866-C-T | not specified | Uncertain significance (Aug 19, 2023) | ||
5-1470869-C-A | Uncertain significance (May 03, 2020) | |||
5-1470875-A-G | not specified | Uncertain significance (May 17, 2023) | ||
5-1470924-T-C | not specified | Uncertain significance (Sep 13, 2023) | ||
5-1474027-G-A | not specified | Uncertain significance (Sep 20, 2024) | ||
5-1474036-A-G | not specified | Uncertain significance (May 25, 2022) | ||
5-1474070-A-C | not specified | Likely benign (Nov 20, 2024) | ||
5-1474561-C-T | not specified | Uncertain significance (Sep 30, 2024) | ||
5-1474569-C-T | not specified | Uncertain significance (Jun 29, 2022) | ||
5-1474576-G-A | not specified | Uncertain significance (Apr 17, 2023) | ||
5-1474576-G-C | not specified | Uncertain significance (May 17, 2023) | ||
5-1474603-C-G | not specified | Uncertain significance (Aug 28, 2024) | ||
5-1474606-C-T | not specified | Uncertain significance (Oct 14, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LPCAT1 | protein_coding | protein_coding | ENST00000283415 | 14 | 67498 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.137 | 0.863 | 125734 | 0 | 13 | 125747 | 0.0000517 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.61 | 254 | 337 | 0.753 | 0.0000233 | 3417 |
Missense in Polyphen | 74 | 131.76 | 0.56162 | 1261 | ||
Synonymous | -1.07 | 167 | 150 | 1.11 | 0.0000118 | 1118 |
Loss of Function | 3.62 | 7 | 27.5 | 0.255 | 0.00000154 | 293 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000185 | 0.000185 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000890 | 0.0000791 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Possesses both acyltransferase and acetyltransferase activities (PubMed:16864775, PubMed:21498505). Activity is calcium-independent (By similarity). Mediates the conversion of 1- acyl-sn-glycero-3-phosphocholine (LPC) into phosphatidylcholine (PC) (PubMed:21498505). Displays a clear preference for saturated fatty acyl-CoAs, and 1-myristoyl or 1-palmitoyl LPC as acyl donors and acceptors, respectively (PubMed:16704971). May synthesize phosphatidylcholine in pulmonary surfactant, thereby playing a pivotal role in respiratory physiology (PubMed:16864775). Involved in the regulation of lipid droplet number and size (PubMed:25491198). {ECO:0000250|UniProtKB:Q3TFD2, ECO:0000269|PubMed:16864775, ECO:0000269|PubMed:21498505, ECO:0000269|PubMed:25491198}.;
- Pathway
- Ether lipid metabolism - Homo sapiens (human);Glycerophospholipid metabolism - Homo sapiens (human);Neutrophil degranulation;Acyl chain remodelling of PG;Metabolism of lipids;Innate Immune System;Immune System;Metabolism;Acyl chain remodelling of PC;Synthesis of PC;Glycerophospholipid biosynthesis;Phospholipid metabolism;Synthesis of PA
(Consensus)
Recessive Scores
- pRec
- 0.166
Intolerance Scores
- loftool
- 0.146
- rvis_EVS
- -0.84
- rvis_percentile_EVS
- 11.4
Haploinsufficiency Scores
- pHI
- 0.0941
- hipred
- Y
- hipred_score
- 0.685
- ghis
- 0.554
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.638
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Lpcat1
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); respiratory system phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- phosphatidic acid biosynthetic process;phosphatidylcholine biosynthetic process;phospholipid biosynthetic process;phosphatidylglycerol acyl-chain remodeling;phosphatidylcholine acyl-chain remodeling;surfactant homeostasis;neutrophil degranulation;positive regulation of protein catabolic process;retina development in camera-type eye;negative regulation of phosphatidylcholine biosynthetic process
- Cellular component
- Golgi membrane;endoplasmic reticulum;endoplasmic reticulum membrane;Golgi apparatus;lipid droplet;plasma membrane;membrane;integral component of membrane;azurophil granule membrane
- Molecular function
- 1-acylglycerol-3-phosphate O-acyltransferase activity;calcium ion binding;2-acylglycerol-3-phosphate O-acyltransferase activity;1-alkenylglycerophosphocholine O-acyltransferase activity;1-acylglycerophosphocholine O-acyltransferase activity;1-alkylglycerophosphocholine O-acyltransferase activity;1-alkylglycerophosphocholine O-acetyltransferase activity